• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

16

CATEGORIES

  • 26
  • 9
  • 7
  • 6
  • 3
  • 2
  • 1
  • 1

PRICE

26
34
43
52

PUBLISHED

0
0
3
52

PRODUCT TYPE

41
11

Search "Ardea Biosciences, Inc." returned 52 results.

PRODUCT TITLE

Ardea Biosciences, Inc. - Product Pipeline Review - 2013

Ardea Biosciences, Inc. – Product Pipeline Review – 2013 Summary Global Market Direct’s pharmaceuticals report, “Ardea Biosciences, Inc. - Product Pipeline Review - 2013” provides data on the Ardea...

May 2013
FROM
Ardea Biosciences, Inc. - Product Pipeline Review - 2012 Ardea Biosciences, Inc. - Product Pipeline Review - 2012 - Product Thumbnail Image

Ardea Biosciences, Inc. - Product Pipeline Review - 2012

Ardea Biosciences, Inc. – Product Pipeline Review – 2012 Summary Global Market Direct’s pharmaceuticals report, “Ardea Biosciences, Inc. - Product Pipeline Review - 2012” provides data on the Ardea...

May 2012
FROM

Ardea Biosciences, Inc. - Strategic SWOT Analysis Review

Ardea Biosciences, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed...

February 2014
FROM
Ardea Biosciences, Inc. (RDEA) - Financial and Strategic SWOT Analysis Review Ardea Biosciences, Inc. (RDEA) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Ardea Biosciences, Inc. (RDEA) - Financial and Strategic SWOT Analysis Review

Ardea Biosciences, Inc. (RDEA) - Financial and Strategic SWOT Analysis Review Summary Ardea Biosciences, Inc. (Ardea Biosciences) is a biotechnology company principally engaged in the discovery and...

September 2011
FROM
Ardea Biosciences, Inc. Company Profile - Business Description, Strategies, SWOT and Financial Analysis Ardea Biosciences, Inc. Company Profile - Business Description, Strategies, SWOT and Financial Analysis - Product Thumbnail Image

Ardea Biosciences, Inc. Company Profile - Business Description, Strategies, SWOT and Financial Analysis

“Ardea Biosciences, Inc. Company Profile” is a comprehensive report on Ardea Biosciences, Inc.. The report provides complete information on the operations, organization structure and financial information...

October 2013
FROM

Ardea Biosciences, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Project Synopsis: Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by...

June 2013
FROM
Ardea Biosciences, Inc. - Product Pipeline Review - H2 2011 Ardea Biosciences, Inc. - Product Pipeline Review - H2 2011 - Product Thumbnail Image

Ardea Biosciences, Inc. - Product Pipeline Review - H2 2011

Ardea Biosciences, Inc. – Product Pipeline Review – H2 2011 Summary Global Market Direct’s pharmaceuticals report, “Ardea Biosciences, Inc. – Product Pipeline Review – H2 2011” provides data on the...

September 2011
FROM
Ardea Biosciences, Inc. - Product Pipeline Review - Q1 2011 Ardea Biosciences, Inc. - Product Pipeline Review - Q1 2011 - Product Thumbnail Image

Ardea Biosciences, Inc. - Product Pipeline Review - Q1 2011

Ardea Biosciences, Inc. – Product Pipeline Review – Q1 2011 Summary Global Market Direct’s pharmaceuticals report, “Ardea Biosciences, Inc. - Product Pipeline Review - Q1 2011” provides data on the...

March 2011
FROM
Ardea Biosciences, Inc. - Product Pipeline Review - Q4 2010 Ardea Biosciences, Inc. - Product Pipeline Review - Q4 2010 - Product Thumbnail Image

Ardea Biosciences, Inc. - Product Pipeline Review - Q4 2010

Ardea Biosciences, Inc. – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “Ardea Biosciences, Inc. - Product Pipeline Review - Q4 2010” provides data on the...

November 2010
FROM
Ardea Biosciences, Inc.-Therapeutic Competitors Ardea Biosciences, Inc.-Therapeutic Competitors - Product Thumbnail Image

Ardea Biosciences, Inc.-Therapeutic Competitors

Ardea Biosciences, Inc.-Therapeutic Competitors Report includes a business summary, tabular representation of the number and percentage of products in each therapeutic indication, all company products...

March 2011
FROM
Ardea Biosciences, Inc.-Detailed Product Pipeline Ardea Biosciences, Inc.-Detailed Product Pipeline - Product Thumbnail Image

Ardea Biosciences, Inc.-Detailed Product Pipeline

Ardea Biosciences, Inc.-Detailed Product Pipeline Report contains detailed information on pipelines by phase and therapeutic indication as well as management information,deals and alliances and recent...

March 2011
FROM
Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements] Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements] - Product Thumbnail Image

Pharma and Biotech M&A Trends 2009-2014 [old name Merger & Acquisition Terms and Agreements]

The Pharma and Biotech M&A Trends 2009-2014 report provides comprehensive understanding and unprecedented access to the merger and acquisition agreements entered into by the worlds leading biopharma...

July 2014
FROM
Competitor Analysis: HIV Small Molecule Therapeutics Competitor Analysis: HIV Small Molecule Therapeutics - Product Thumbnail Image

Competitor Analysis: HIV Small Molecule Therapeutics

The present Competitive Intelligence report about HIV Small Molecule Therapeutics used to treat human immunodeficiency virus (HIV) infections provides a competitor evaluation in the field of marketed...

December 2011
FROM

Hyperuricemia - Pipeline Review, H1 2013

Hyperuricemia – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Hyperuricemia - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

May 2013
FROM

Hyperuricemia Global Clinical Trials Review, H2, 2012

Hyperuricemia Global Clinical Trials Review, H2, 2012 Summary Our clinical trial report, “Hyperuricemia Global Clinical Trials Review, H2, 2012" provides data on the Hyperuricemia clinical trial scenario....

October 2012
FROM
Gouty Arthritis (Gout) - Pipeline Review, H1 2013 Gouty Arthritis (Gout) - Pipeline Review, H1 2013 - Product Thumbnail Image

Gouty Arthritis (Gout) - Pipeline Review, H1 2013

Gouty Arthritis (Gout) – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Gouty Arthritis (Gout) - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline....

February 2013
FROM
Hyperuricemia - Pipeline Review, H2 2012 Hyperuricemia - Pipeline Review, H2 2012 - Product Thumbnail Image

Hyperuricemia - Pipeline Review, H2 2012

Hyperuricemia – Pipeline Review, H2 2012 Summary Global Markets Direct’s, 'Hyperuricemia - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides...

November 2012
FROM

HIV / AIDS – Pipeline Review, H1 2013

Global Markets Direct’s, 'HIV / AIDS - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline This report provides information on the therapeutic development for HIV...

February 2013
FROM

HIV / AIDS - Pipeline Review, H2 2013

HIV / AIDS - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'HIV / AIDS - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides...

July 2013
FROM

Gouty Arthritis (Gout) Global Clinical Trials Review, H2, 2012

Gouty Arthritis (Gout) Global Clinical Trials Review, H2, 2012 Summary Our clinical trial report, “Gouty Arthritis (Gout) Global Clinical Trials Review, H2, 2012" provides data on the Gouty Arthritis...

October 2012
FROM
Loading Indicator